These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9150373)

  • 1. Effect of nordihydroguaretic acid and fluconazole on the LTC4/PGE2 ratio in the kidney of mice damaged by Candida albicans.
    Kuştimur S; Memiş L; Kilinç M; Ercan ZS
    Prostaglandins Leukot Essent Fatty Acids; 1997 Apr; 56(4):281-3. PubMed ID: 9150373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of indomethacin, NDGA, allopurinol and superoxide dismutase on prostaglandin E2 and leukotriene C4 levels after mesenteric ischemia-reperfusion injury.
    Sare M; Bozkurt S; Onuk E; Oguz M; Gurel M; Ercan S
    Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):379-83. PubMed ID: 9014215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of eicosanoids in the kidney damage induced by Candida albicans.
    Kuştimur S
    Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):83-4. PubMed ID: 1438470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosanoid and gastroprotection by copper derivatives and NDGA.
    Franco L; Velo GP
    Inflamm Res; 1995 Mar; 44(3):139-42. PubMed ID: 7552579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nordihydroguaiaretic acid on leukotriene C4 and prostaglandin E2 production following different reperfusion periods in rat brain after forebrain ischemia correlated with morphological changes.
    Aktan S; Aykut C; Yegen BC; Okar I; Ozkutlu U; Ercan S
    Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):633-41. PubMed ID: 8415814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
    Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
    Najvar LK; Correa A; James P; Luther MF; Graybill JR
    J Antimicrob Chemother; 1996 Oct; 38(4):671-7. PubMed ID: 8937961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
    Onyewu C; Afshari NA; Heitman J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3963-5. PubMed ID: 16923949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
    Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
    J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model.
    Khan MA; Aljarbou AN; Khan A; Younus H
    Int J Biol Macromol; 2015 May; 76():203-8. PubMed ID: 25709021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
    Bannatyne RM; Cheng PC; Fong IW
    Infection; 1992; 20(3):168-70. PubMed ID: 1644494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tinospora cordifolia Aqueous Extract Alleviates Cyclophosphamide- Induced Immune Suppression, Toxicity and Systemic Candidiasis in Immunosuppressed Mice: In vivo Study in Comparison to Antifungal Drug Fluconazole.
    Alrumaihi F; Allemailem KS; Almatroudi A; Alsahli MA; Khan A; Khan MA
    Curr Pharm Biotechnol; 2019; 20(12):1055-1063. PubMed ID: 31333126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid and its metabolites effects on testosterone production by rat Leydig cells.
    Romanelli F; Valenca M; Conte D; Isidori A; Negro-Vilar A
    J Endocrinol Invest; 1995 Mar; 18(3):186-93. PubMed ID: 7615904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.
    Wang Y; Jia XM; Jia JH; Li MB; Cao YY; Gao PH; Liao WQ; Cao YB; Jiang YY
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e40-6. PubMed ID: 19413603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
    Kamai Y; Kakuta M; Shibayama T; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Jan; 49(1):52-6. PubMed ID: 15616275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
    Shi J; Li S; Gao A; Zhu K; Zhang H
    Phytomedicine; 2018 Jul; 46():21-31. PubMed ID: 30097119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.
    Shen H; An MM; Wang de J; Xu Z; Zhang JD; Gao PH; Cao YY; Cao YB; Jiang YY
    Biol Pharm Bull; 2007 Jan; 30(1):68-73. PubMed ID: 17202662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.